1-20 of 29
Robert F. Sidonio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TFPI blockade: removing coagulation’s brakes

Robert F. Sidonio, Jr, Karen L. Zimowski
Blood (2019) 134 (22): 1885–1887.
DOI: https://doi.org/10.1182/blood.2019002900
Published: 2019
Journal Articles

Clinical Study to Investigate the Efficacy and Safety of Wilate during Prophylaxis in Previously Treated Patients with Von Willebrand Disease (VWD)

Robert F. Sidonio, Jr., MD MSc, Bruce A. Schwartz, PhD
Blood (2019) 134 (Supplement_1): 4931.
DOI: https://doi.org/10.1182/blood-2019-128339
Published: 2019
Journal Articles

Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers

Lynn M Malec, MD, Stacy E. Croteau, Michael Callaghan, MD, Davide Matino, MD MSc, Kenneth Dale Friedman, MD, Robert F. Sidonio, Jr., MD MSc
Blood (2019) 134 (Supplement_1): 2407.
DOI: https://doi.org/10.1182/blood-2019-126196
Published: 2019
Journal Articles

Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels

Megan C. Brown, MD, Michael H. White, MD, Robert F. Sidonio, Jr., MD MSc
Blood (2019) 134 (Supplement_1): 627.
DOI: https://doi.org/10.1182/blood-2019-127258
Published: 2019
Journal Articles

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Julie Jaffray, MD, Robert F. Sidonio, Jr., MD MSc, Jemily Malvar, MS, Janice M Staber, MD, Kristina M. Haley, DO, Amy Stillings, Angela C. Weyand, MD, Sarah H. O'Brien, MD, Peter A. Kouides, MD
Blood (2019) 134 (Supplement_1): 628.
DOI: https://doi.org/10.1182/blood-2019-122379
Published: 2019
Journal Articles

Thrombotic Outcomes Following Hormonal Treatment of Heavy Menstrual Bleeding in Pediatric Patients Taking Anticoagulation

Michael H. White, MD, Gary Woods, MD, Robert F. Sidonio, Jr., MD MSc
Blood (2019) 134 (Supplement_1): 2179.
DOI: https://doi.org/10.1182/blood-2019-130100
Published: 2019
Journal Articles

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial

Margaret V. Ragni, MD MPH, Craig D. Seaman, MD MS, Diana Gilligan, MD, Claire S. Philipp, MD, Anne T. Neff, MD, Robert F. Sidonio, Jr., MD MSc, Philip Kuriakose, MD, Tzu-Fei Wang, MD MPH, Lynn M. Malec, MD, Rajiv K. Pruthi, MBBS, Elaine Majerus, MD PhD, George M. Rodgers, MD PhD, Danielle Nance, MD, Nina Hwang, MD, Barbara A. Konkle, MD, Andrew D. Leavitt, MD, Joseph Lasky, MD, Allison P. Wheeler, MD, Roshni Kulkarni, MD, Tammuella Singleton, MD, Dana Ivanco, Elynna Youm, BA, Glory Koerbel, MSN, RN, Scott Rothenberger, PhD, Doris M. Rubio, PhD
Blood (2019) 134 (Supplement_1): 1130.
DOI: https://doi.org/10.1182/blood-2019-124234
Published: 2019
Journal Articles

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

Robert F. Sidonio, Jr., MD MSc, Angela C. Weyand, MD, Dunlei Cheng, PhD, Crystal Watson
Blood (2019) 134 (Supplement_1): 1132.
DOI: https://doi.org/10.1182/blood-2019-128318
Published: 2019
Journal Articles

Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome

Robert F. Sidonio, Jr., MD MSc, Dunlei Cheng, PhD, Christine Guelcher, PPCNP-BC, Janna M. Journeycake, MD, Susan U Lattimore, Clifford Takemoto, MD, Michael D. Tarantino, MD, Crystal Watson, Ellis J. Neufeld, MD, Carol Fedor, RN
Blood (2019) 134 (Supplement_1): 1114.
DOI: https://doi.org/10.1182/blood-2019-128612
Published: 2019
Journal Articles

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Paulette Bryant, MD, Jenny McDaniel, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD MSc
Blood (2019) 134 (Supplement_1): 1126.
DOI: https://doi.org/10.1182/blood-2019-126659
Published: 2019
Journal Articles

Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States

Lynn M. Malec, MD, Char M Witmer, MDMSCE, Julie Jaffray, MD, Peter A. Kouides, MD, Kristina M. Haley, DO, Robert F. Sidonio, Jr., MD, Dunlei Cheng, PhD, Thomas C. Abshire, MD, Gilbert C. White, MD, Margaret V. Ragni, MD MPH
Blood (2018) 132 (Supplement 1): 1195.
DOI: https://doi.org/10.1182/blood-2018-99-113956
Published: 2018
Journal Articles

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Joan Cox Gill, MD, Kenneth Dale Friedman, MD, Sandra L Haberichter, PhD, Jorge Di Paola, MD, Paula D. James, MD, Janna M. Journeycake, MD, Steven R. Lentz, MD PhD, Cindy A. Leissinger, MD, Margaret V. Ragni, MD MPH, Madhvi Rajpurkar, MD, Jonathan C. Roberts, MD, Amy Shapiro, Robert F. Sidonio, Robert R Montgomery, MD, Thomas C. Abshire, MD
Blood (2018) 132 (Supplement 1): 979.
DOI: https://doi.org/10.1182/blood-2018-99-110650
Published: 2018
Journal Articles

Emicizumab Prophylaxis Provides Flexible and Effective Bleed Control in Children with Hemophilia Α with Inhibitors: Results from the HAVEN 2 Study

Guy Young, Ri Liesner, Robert F. Sidonio, Jr., Johannes Oldenburg, Victor Jimenez-Yuste, Johnny Mahlangu, Rebecca Kruse-Jarres, Michael Wang, Tiffany Chang, Marianne Uguen, Michelle Doral, Christophe Schmitt, Gallia G. Levy, Midori Shima, MD PhD, Maria Elisa Mancuso
Blood (2018) 132 (Supplement 1): 632.
DOI: https://doi.org/10.1182/blood-2018-99-118153
Published: 2018
Journal Articles

The Atlanta Protocol: Immune Tolerance Induction in Pediatric Patients with Hemophilia a and Inhibitors on Emicizumab

Glaivy M. Batsuli, MD, Karen L. Zimowski, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD
Blood (2018) 132 (Supplement 1): 634.
DOI: https://doi.org/10.1182/blood-2018-99-114249
Published: 2018
Journal Articles

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Mark T. Reding, MD, Jatin Rana, MD, Michael U. Callaghan, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD
Blood (2018) 132 (Supplement 1): 635.
DOI: https://doi.org/10.1182/blood-2018-99-115089
Published: 2018
Journal Articles

Bleeding Severity and Health Care Utilization in Patients with Platelet Function Disorders

Divyaswathi Citla Sridhar, MD, Sneha Butala, MD, Anjali Shekar, Robert F. Sidonio, Jr., MD, Sanjay Ahuja
Blood (2018) 132 (Supplement 1): 4994.
DOI: https://doi.org/10.1182/blood-2018-99-119403
Published: 2018
Journal Articles

Model of the Impact of Delayed Inhibitor Development on Cumulative Breakthrough Bleeds and Costs in Persons with Hemophilia A Receiving Emicizumab Prophylaxis

Robert F. Sidonio, Jr., Anisha Patel, Shelby Corman, Stephen Chaplin, Karina Raimundo
Blood (2018) 132 (Supplement 1): 4710.
DOI: https://doi.org/10.1182/blood-2018-99-116410
Published: 2018
Journal Articles

Ethical Decision Making Framework in Previously Untreated Severe Hemophilia A Patients

Ashley Foster Lanzel, MD, J. Michael Soucie, PhD, Shannon L. Meeks, MD, Robert F. Sidonio, Leonard Ortmann, PhD, Drue H Barrett, PhD
Blood (2017) 130 (Supplement 1): 5583.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.5583.5583
Published: 2017
Journal Articles

HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors

Guy Young, Robert F. Sidonio, Ri Liesner, Johannes Oldenburg, Tiffany Chang, Marianne Uguen, Christophe Dhalluin, Christophe Schmitt, Gallia G. Levy, Midori Shima, MDPhD, Johnny Mahlangu
Blood (2017) 130 (Supplement 1): 85.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.85.85
Published: 2017
Journal Articles

US Economic Impact of Recombinant FVIII Vs Plasma-Derived FVIII/VWF in Previously Untreated Hemophilia a Patients

Robert F. Sidonio, M. Chris Runken, Ken O'Day, Kellie Meyer, Jeffrey Spears
Blood (2017) 130 (Supplement 1): 2088.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2088.2088
Published: 2017